HSA — authorised 19 November 1991
- Marketing authorisation holder: PFIZER PHARMS
- Status: likely_approved
HSA authorised Accupril on 19 November 1991
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 19 November 1991.
PFIZER PHARMS holds the Singaporean marketing authorisation.